Press release
Global Urinary Tract Cancer Market Outlook 2025-2034: Trends, Innovations, And Future Outlook
Urinary Tract Cancer Market Size
What Is the Urinary Tract Cancer Market Size and Projected Growth Rate?
In recent times, the market size for urinary tract cancer has experienced exponential growth. The market, which is expected to be valued at $3.21 billion in 2024, is set to expand to $3.87 billion in 2025 with a compound annual growth rate (CAGR) of 20.6%. The increase during the historic period can be traced back to enhancements in diagnostics, advances in the pharmaceutical sector, rising awareness and early detection, along with progress in precision medicine.
The market value for urinary tract cancer is projected to experience a significant increase over the upcoming years, reaching $7.74 billion by 2029 with an 18.9% compound annual growth rate (CAGR). Such growth over the predicted period can be attributed to several factors including advancements in immunotherapy, the use of telemedicine and remote tracking, research into biomarkers, and auxiliary therapies. The forecast period will also witness key trends such as global collaboration, advancements in end-of-life care, all-encompassing programs for survivors, and a focus on patient-centered care.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13059
What Are the Major Segments in the Urinary Tract Cancer Market?
The urinary tract cancer market covered in this report is segmented -
1) By Cancer Type: Bladder Cancer, Urethral Cancer, Ureteric And Renal Pelvic Cancer
2) By Treatment: Chemotherapy, Intravesical Therapy, Radiation Therapy, Surgery
3) By Diagnostic Techniques: Cystoscopy, Transurethral Resection Of The Tumor, Imaging Tests, Urine Analyses, Other Diagnostic Techniques
4) By Distribution Channel: Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Bladder Cancer: Transitional Cell Carcinoma, Squamous Cell Carcinoma, Adenocarcinoma, Other Types
2) By Urethral Cancer: Urethral Carcinoma, Other Urethral Tumors
3) By Ureteric And Renal Pelvic Cancer: Ureteric Cancer, Renal Pelvic Cancer, Other Types
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13059&type=smp
What Are The Driving Urinary Tract Cancer Market Evolution?
The increasing occurrence of bladder cancer is projected to boost the urinary tract cancer market's expansion. Bladder cancer is the formation of cancer cells within the urinary bladder tissues. The urinary bladder is a hollow organ located within the pelvis that is responsible for storing the kidneys' urine until it's ready to be ejected from the body. This rise leads to a higher demand for diagnostic equipment, screening procedures, and treatment options for urinary tract cancer patients. For instance, in January 2023, a report by the American Cancer Society Inc., a US-based voluntary cancer awareness group, predicted that the number of urinary system cancer cases would rise to 168,560 in 2023, marking a 2.66% increase from 164,190 cases in 2022 in the United States. Hence, the increasing occurrence of bladder cancer is anticipated to fuel the urinary tract cancer market's growth. Urinary Tract Cancer Market Driver: Rising Urinary Tract Infection Rates Propelling The Urinary Tract Cancer Market Growth
Which Firms Dominate The Urinary Tract Cancer Market Segments?
Major companies operating in the urinary tract cancer market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck KGaA, Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC (GSK), Eli Lilly and Company, Amgen Inc., Astellas Pharma Inc., Eisai Co. Ltd., Boehringer Ingelheim GmbH, Incyte Corporation, Shionogi & Co. Ltd., Kyowa Hakko Kirin Co. Ltd., Endo International PLC, Seagen Inc., Exelixis Inc., Ferring Pharmaceuticals, Bavarian Nordic, EUSA Pharma, UroGen Pharma Inc., Mersana Therapeutics, Protara Therapeutics Inc., Spectrum Pharmaceuticals, IDL Biotech AB, AroCell AB, ImmunityBio Inc.
What Trends Are Expected to Dominate the Urinary Tract Cancer Market in the Next 5 Years?
Leading organizations involved in the urinary tract cancer market are amplifying their emphasis on innovation in therapy methods to deliver more efficient and personalized treatments, competing for an advantage in the industry. These breakthroughs spotlight accurate procedures, harnessing the body's immune response, surgical technique enhancements, and tailoring therapies for the distinct requirements of each patient. As an example, UC San Diego Health, a healthcare entity based in the United States, introduced a cutting-edge treatment in October 2022 for individuals affected by low-grade upper tract urothelial cancer (LG-UTUC), a comparatively rare variant of urinary system cancer. This novel treatment presents an optional pathway to the conventional approach of entirely removing the kidney, potentially saving patients from future dialysis or kidney transplantation procedures. This ground-breaking treatment involves the use of a drug, Jelmyto, dispensed through a series of injections containing mitomycin, a recognized chemotherapy substance, and a sterile hydrogel. The drug's administration is conducted through guided injections, allowing precise targeting of the tumor's position within the urinary system.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/urinary-tract-cancer-global-market-report
Which Is The Largest Region In The Urinary Tract Cancer Market?
North America was the largest region in the urinary tract cancer market in 2024. The regions covered in urinary tract cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Urinary Tract Cancer Market?
2. What is the CAGR expected in the Urinary Tract Cancer Market?
3. What Are the Key Innovations Transforming the Urinary Tract Cancer Industry?
4. Which Region Is Leading the Urinary Tract Cancer Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Urinary Tract Cancer Market Outlook 2025-2034: Trends, Innovations, And Future Outlook here
News-ID: 4032233 • Views: …
More Releases from The Business Research Company
Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billio …
"Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Dermal Regeneration Market Size Forecast for 2025?
In recent years, the market size of dermal regeneration has significantly expanded. Its growth is set to continue, moving from a market value of $1.64 billion in 2024, surging to $1.79 billion in 2025, indicating a Compound Annual Growth Rate…
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Dental Emergency Kit Market from 2024 to 2025?
In recent times, the dental emergency kit market has seen significant growth. Projected growth rates suggest an increase from $1.18 billion in 2024 to $1.28 billion in 2025, manifesting a compound annual growth rate (CAGR) of 8.2%.…
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billio …
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Cryopreservation Equipment Market Size 2025?
The expansion of the cryopreservation equipment market has been significant in recent years. The market which is expected to escalate from $9.52 billion in 2024 to $11.01 billion in 2025, will do so with a compound annual growth rate…
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Connected Wearable Patches Market Grow by 2025 in Terms of Size and Growth?
The market size for connected wearable patches has seen significant expansion in the most recent years. With an expected rise from $5.62 billion in 2024 to $6.42 billion in 2025, representing a compound annual growth rate…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
